Weight regain after Ozempic and Wegovy: how to prevent it

Why can weight return after stopping Ozempic, Wegovy or Mounjaro?

Weight regain has a biological basis. These medicines act on signals related to appetite and blood glucose regulation [2].

During treatment, people usually feel fuller and less hungry. When the medicine is stopped, this effect diminishes and appetite may return. The timing and intensity vary from person to person; there is no set week when this happens. To understand the differences between GLP-1 medicines, see the GLP-1 medicines guide.

How much weight is regained, and how quickly?

A University of Oxford review found an average regain of 0.4 kg per month after stopping weight-management medication [1]. For newer medicines, the estimate was around 0.8 kg per month [1]. After a programme based only on diet and physical activity, weight returned more slowly [1]. These are group averages, not an individual prediction.

The same review projected a return to starting weight after approximately a year and a half with the newer medicines [1]. This projection does not mean that everyone regains all the weight. Some improvements in blood pressure, glucose and lipids may also be lost [1].

In a trial with Mounjaro, participants who stopped the medicine after 36 weeks regained an average of 14% of their weight over the following year, under the treatment schedule studied [2]. Those who continued lost an additional average of 5.5% [2]. This result describes the trial groups; it cannot predict how much weight you will regain.

Wegovy data point in the same direction. One year after stopping treatment, participants had regained an average of two-thirds of the weight they had lost, under the treatment schedule studied [3]. Blood pressure, glucose and lipids gradually returned to their starting levels [3].

Why can losing muscle make weight regain harder?

When weight drops quickly, some of the weight lost may be muscle mass as well as fat. Losing muscle can also reduce the energy the body uses at rest.

If your appetite returns after muscle loss, maintaining your weight may be harder. Exercise also protects bone: in a trial, people who combined a GLP-1 medicine with scheduled exercise maintained bone density better than those who took the medicine alone [4].

A joint recommendation from four US scientific societies for obesity, nutrition and lifestyle advises combining these medicines with strength training on two or more days a week, adapted to each person [5]. Read more in protein and muscle during GLP-1 treatment.

What to do while you are still taking the medicine

Preventing weight regain starts during treatment. This is the time to use the period of reduced hunger to establish sustainable routines.

First, focus on protein. Include protein-rich foods in your main meals while losing weight [5]. This helps protect lean mass and supports satiety.

Second, start strength training during treatment, adapted to your circumstances. Walking supports cardiovascular health; weights, machines or resistance bands provide the stimulus your muscles need.

What should you eat after stopping Ozempic, Wegovy or Mounjaro?

When preparing to stop, the structure of your plate matters. The most practical tool is the plate method. Half the plate is vegetables, one quarter is protein and the other quarter is complex carbohydrates such as potatoes, pulses or whole grains.

Vegetables and pulses provide fibre and volume. We adjust portions to your appetite and activity, without imposing a rigid plan. For meal ideas, see what to eat with GLP-1 and a weekly menu.

A plan for before, during and after your last dose

Your plan for stopping treatment starts before your last dose. If you are worried about stopping Ozempic, Wegovy or Mounjaro, speak first with the prescriber. They decide whether treatment should continue, be adjusted or be stopped. No adjustment guarantees that weight regain will be prevented; do not change your plan on your own.

In nutrition care, we prepare a written plan for schedules, easy meals and a manageable strength routine. We note how you are doing when you stop so that we can recognise changes without judging you by a single number. If you weigh yourself, do so no more than once a week. Use waist and hip measurements, or a familiar belt, as a reference.

1. At each treatment adjustment. We review hunger, fullness, discomfort and frequent thoughts about food; then adapt amounts and meal times.
2. After the last dose and through month three. We review the weekly record and adjust meals and strength training.
3. Months four to six. We check which routines you can maintain and whether you need more support with meal planning.
4. Months seven to twelve. We review the trend and adapt follow-up to your circumstances.

Each week, you can note whether hunger starts earlier, whether you need to bring a meal forward or whether you find yourself thinking about food more often again. Some days will be similar to the ones before; on others, amounts may need adjusting. Keeping a record helps identify the trend and arrange an earlier appointment if a change worries you.

If binge eating, guilt or intense fear of eating returns, we can offer psychological support. With your consent, we share relevant changes with your doctor.

Feeling hungry again after stopping the medicine does not mean you have done anything wrong. This is the time to use and adjust the plan you prepared.

What if your doctor recommends continuing treatment?

Continuing treatment may be an option your doctor considers based on the medicine and your progress. The decision requires individual follow-up.

While you continue taking it, we maintain the meal structure and strength training. If it is stopped later, weight may increase again [1] [2]. Your medical team reviews whether to continue or change the plan; we support your diet and physical activity.

Where to check the official guidance

The Summary of Product Characteristics for each medicine sets out its indications. It is published by the Spanish Agency of Medicines and Medical Devices [6]. These medicines are not a way to lose a few kilos before an event.

The product information explains who each medicine is authorised for [6]. Your doctor considers this information alongside your clinical circumstances [6].

Ozempic, Wegovy and Mounjaro have different indications [6]. For this reason, the prescriber should assess each case [6].

The indication depends on the medicine. You can consult the information about Ozempic, Wegovy and Mounjaro. Starting, changing the dose or stopping treatment is a decision for your doctor. The nutrition team works in coordination with the prescriber.

What mistakes do we see in consultations?

• Waiting until the last pen to start changing your diet. By then, hunger may already be returning.
• Eating so little during treatment that you do not get enough protein. When hunger is suppressed, some days may be managed with just coffee and biscuits.
• Walking a lot but doing no strength training. Weight goes down, and more muscle than necessary may be lost along with it.
• Stopping the medicine abruptly because of the cost or side effects without talking to the prescriber.
• Interpreting one isolated increase as a failure. We review the trend and the plan before drawing conclusions.

How we support you during and after treatment

Our aim is to care for your body composition and help you maintain autonomy with food over the long term.

During treatment, the dietitian calculates your needs for protein, micronutrients and fibre. They also adjust textures and meal times to ease nausea or stomach discomfort.